Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Farmers Insurance
Baxter
Julphar
Moodys
Daiichi Sankyo
Cipla
US Department of Justice
McKesson

Generated: October 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020468

« Back to Dashboard

NDA 020468 describes NASACORT ALLERGY 24 HOUR, which is a drug marketed by Sanofi Aventis Us and is included in one NDA. It is available from three suppliers. Additional details are available on the NASACORT ALLERGY 24 HOUR profile page.

The generic ingredient in NASACORT ALLERGY 24 HOUR is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Eighty-five suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
Summary for 020468
Tradename:NASACORT ALLERGY 24 HOUR
Applicant:Sanofi Aventis Us
Ingredient:triamcinolone acetonide
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020468
Medical Subject Heading (MeSH) Categories for 020468
Suppliers and Packaging for NDA: 020468
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NASACORT ALLERGY 24 HOUR triamcinolone acetonide SPRAY, METERED;NASAL 020468 NDA sanofi-aventis U.S. LLC 0075-1506 0075-1506-16 120 SPRAY, METERED in 1 BOTTLE, SPRAY (0075-1506-16)
NASACORT ALLERGY 24 HOUR triamcinolone acetonide SPRAY, METERED;NASAL 020468 NDA Chattem, Inc. 41167-5800 41167-5800-1 1 BOTTLE, SPRAY in 1 CARTON (41167-5800-1) > 30 SPRAY, METERED in 1 BOTTLE, SPRAY

Profile for product number 002

Active Rx/OTC/Discontinued:OTCDosage:SPRAY, METERED;NASALStrength0.055MG/SPRAY
Approval Date:Oct 11, 2013TE:RLD:Yes

Expired US Patents for NDA 020468

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us NASACORT ALLERGY 24 HOUR triamcinolone acetonide SPRAY, METERED;NASAL 020468-002 Oct 11, 2013 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us NASACORT ALLERGY 24 HOUR triamcinolone acetonide SPRAY, METERED;NASAL 020468-002 Oct 11, 2013 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us NASACORT ALLERGY 24 HOUR triamcinolone acetonide SPRAY, METERED;NASAL 020468-002 Oct 11, 2013 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Teva
Medtronic
Harvard Business School
Covington
Fish and Richardson
QuintilesIMS
UBS
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.